Global Vertebroplasty Needles Market Size By Type (2.5x100, 2.5x130), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Vertebroplasty Needles Market was valued at USD 820 million in 2023 and is projected to reach USD 1.35 billion by 2031, growing at a CAGR of 6.5% during the forecast period from 2023 to 2031. The market is witnessing significant growth driven by the rising incidence of osteoporosis-related fractures, increased adoption of minimally invasive procedures, and advancements in vertebral augmentation technologies. Vertebroplasty needles are essential tools in the vertebroplasty procedure, which is used to treat vertebral compression fractures and provide rapid pain relief. As the geriatric population expands globally and awareness about spinal treatment options increases, the demand for vertebroplasty needles is expected to surge.

Drivers:

1. Rising Geriatric Population and Osteoporotic Cases:

An aging global population is leading to a higher prevalence of osteoporosis, a major cause of vertebral compression fractures. This demographic shift is significantly boosting the demand for vertebroplasty procedures and, consequently, vertebroplasty needles.

2. Increasing Preference for Minimally Invasive Procedures:

Vertebroplasty offers a less invasive alternative to traditional surgery with quicker recovery times and lower complication rates. The preference for such procedures among patients and physicians alike is accelerating market growth.

3. Technological Advancements in Needle Design:

Recent innovations such as directional and curved needles have enhanced the precision and safety of vertebroplasty procedures, expanding their applicability and adoption.

Restraints:

1. Procedural Complications and Safety Concerns:

Although vertebroplasty is generally safe, potential risks such as cement leakage and adjacent vertebral fractures can deter adoption, especially in risk-averse healthcare settings.

2. Reimbursement Limitations in Certain Regions:

Inconsistent or limited reimbursement policies, especially in developing nations, can restrict access to vertebroplasty procedures and limit the market potential for related medical tools.

Opportunity:

1. Growing Demand in Emerging Markets:

Expanding healthcare infrastructure and increasing awareness in countries across Asia-Pacific and Latin America offer untapped potential for market players.

2. Integration with Imaging and Navigation Systems:

The integration of vertebroplasty needles with advanced imaging guidance (e.g., CT or fluoroscopy) improves procedural accuracy and safety, presenting new growth avenues.

Market by System Type Insights:

Based on system type, curved vertebroplasty needles held the largest market share in 2023 due to their enhanced ability to reach complex vertebral anatomy. These needles offer better navigation within the vertebra and reduced cement leakage risk. The segment is expected to maintain dominance throughout the forecast period, fueled by ongoing improvements in interventional radiology techniques.

Market by End-use Insights:

In 2023, hospitals emerged as the dominant end-user segment, accounting for more than 60% of the market revenue. Hospitals perform a large volume of vertebroplasty procedures due to the availability of skilled professionals and advanced imaging technologies. However, ambulatory surgical centers (ASCs) are expected to witness the fastest growth due to cost efficiency and reduced hospital stay durations.

Market by Regional Insights:

North America held the largest market share in 2023, driven by a well-established healthcare system, high diagnosis rates of spinal conditions, and rapid adoption of minimally invasive technologies. The Asia-Pacific region is projected to experience the fastest growth due to its large aging population, increasing healthcare access, and expanding awareness of spinal treatments in countries like China and India.

Competitive Scenario:

Key players in the Global Vertebroplasty Needles Market include:

Medtronic plc

Stryker Corporation

BD (Becton, Dickinson and Company)

Merit Medical Systems, Inc.

Johnson & Johnson (DePuy Synthes)

Zavation Medical Products

IZI Medical Products

G21 S.r.l.

These companies are investing in R&D, pursuing regulatory approvals for new products, and expanding globally through strategic partnerships and acquisitions.

Recent Developments:

In 2023, Stryker launched a new generation of curved vertebroplasty needles with improved steerability and cement control.

BD announced in 2024 the FDA approval of a new vertebroplasty system integrated with real-time imaging for enhanced accuracy.

In 2025, Merit Medical Systems expanded its footprint in Asia by establishing a new manufacturing facility in Singapore dedicated to spinal products.

Scope of Work – Global Vertebroplasty Needles Market

Report Metric Details

Market Size (2023) USD 820 million

Projected Market Size (2031) USD 1.35 billion

CAGR (2023–2031) 6.5%

Market Segments By System Type (Curved, Straight), By End-use (Hospitals, ASCs, Clinics)

Growth Drivers Aging population, preference for minimally invasive procedures, technology

Opportunities Emerging markets, integration with advanced imaging systems

Key Market Developments:

2023: Stryker introduces high-precision curved needles for improved targeting in vertebroplasty procedures.

2024: BD secures FDA clearance for its vertebroplasty toolkit with real-time imaging compatibility.

2025: Medtronic expands its spine portfolio with cement augmentation tools optimized for multi-level fractures.

FAQs:

1) What is the current market size of the Global Vertebroplasty Needles Market?

The market was valued at USD 820 million in